Epstein Secrets

immigration lawyers, that the American Civil Liberties Union and other groups tried in earnest to begin reuniting them." The New York Times (10/21, Dickerson, Thrush, 18.61M) reports that on Wednesday, Joe Biden "called President Trump's border policy an 'outrage' and a 'moral failing' that he would reve

the children were released from government custody to sponsors in the United States, often family members." According to the New York Times (10/21, Dickerson, 18.61M), "A new report shows hundreds of cases in which migrant children were taken from their families, and their parents, who were deported, can

potential vaccines." According to the AP, Brazil's health minister Eduardo Pazuello "had announced the purchase on Tuesday." Brazilian Volunteer In AstraZeneca Vaccine Trial Dies. The CBS Evening NewsVi (10/21, story 4, 0:25, O'Donnell, 4.55M) reported, "Tonight, health officials in Brazil report that a vo

6 States, often family members." According to the New York Times <https://www.nytimes.corn/2020/10/21/us/migrant-children-separated.html> (10/21, Dickerson, 18.61M), "A new report shows hundreds of cases in which migrant children were taken from their families, and their parents, who were deported, cann

potential vaccines." According to the AP, Brazil's health minister Eduardo Pazuello "had announced the purchase on Tuesday." Brazilian Volunteer In AstraZeneca Vaccine Trial Dies. The CBS Evening News <https://playvideo.bulletinintelligence.corn/93052blfaf294 1 1 la0d8d20e31407e5c?pubid=fbi> (10/21, story 4

rate effort to stay six feet away from others." Rio Grande Valley Residents Especially Vulnerable To Effects Of Pandemic. The New York Times (7/19, Dickerson, Addario, 18.61M) reports the coronavirus pandemic is "bearing down on some of the places most vulnerable to its devastation - places like the sout

accine." CBS (Tyab) added, "The Serum Institute of India is the world's largest manufacturer of vaccines and has been tapped by pharmaceutical giant AstraZeneca to produce over a billion doses of the vaccine being trialed by Oxford University." If the trials are successful, "there is still serious concerns